MedPath

Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes

Conditions
Diabetes Mellitus
Diabetic Retinopathy
Registration Number
NCT01517490
Lead Sponsor
Glostrup University Hospital, Copenhagen
Brief Summary

Retinal function is highly dependent on the glucose supply. Thus, functional adaptations occur in response to both acute and long-term changes in glycaemia.

The purpose of this study is to examine functional and metabolic aspects of retinal adaptation to long-lasting changes in glycaemic control in patients with diabetes. The adaptational phenomena will be characterized by electroretinography, dark adaptation, measures of retinal perfusion and oximetry as well as diabetic retinopathy grading and (OCT).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients with type 1 diabetes and suboptimal metabolic regulation.
  • Patients with type 2 diabetes and suboptimal metabolic regulation.
Exclusion Criteria
  • Significant cataract
  • Glaucoma
  • Proliferative diabetic retinopathy fulfilling ETDRS treatment criteria.
  • Clinically significant macular edema fulfilling ETDRS treatment criteria.
  • Age-related macular degeneration
  • Prior surgery to the eye
  • Other serious eye disease
  • Hypertension

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in dark adaptation kinetics and threshold values, amplitudes/implicit times, retinal vessel diameters, perfusion velocity and oximetry.Baseline, 1 week, 1 month, 4 months, 7 months, 12 months, 18 months, 24 months, 42 months
Changes in visual acuity, diabetic retinopathy grading and OCTBaseline, 1 week, 1 month, 4 months, 7 months, 12 months, 18 months, 24 months, 42 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Ophthalmology, Glostrup Hospital

🇩🇰

Glostrup, Denmark

Department of Ophthalmology, Glostrup Hospital
🇩🇰Glostrup, Denmark
Oliver Klefter, MD
Principal Investigator
Michael Larsen, Professor, DMSci
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.